Form D · Biotechnology
MB Holdings 2025, Inc.
Pasadena, TX · CIK 0002058983
Offering snapshot reported Mar 4, 2025 · SEC filing
- Reported sold
- $6.17M Offering amount: $6.17M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 14, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 4, 2025 | Initial | $6,165,322 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-539774
Source: Form D, filed Mar 4, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Kevin Combs | Director |
| David Manka | Director |
| Armando Martinez | Director |
| Arturo Martinez | Director |
| Steve Rakes | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5413 Crenshaw Road
Pasadena, TX, 77505
Pasadena, TX, 77505